Critical role of AZI2 in GM-CSF-induced dendritic cell differentiation

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5702-5711

  Fukasaka, Masahiro ^a,b   Ori, Daisuke ^a,c,d   Kawagoe, Tatsukata ^a,f   Uematsu, Satoshi ^a,g   Maruyama, Kenta ^a   Okazaki, Toshihiko ^a,b   Kozaki, Tatsuya ^a   Imamura, Tomoko ^a,c,d   Tartey, Sarang ^a,c,d   Mino, Takashi ^c,d   Satoh, Takashi ^a   Akira, Shizuo ^a,e   Takeuchi, Osamu ^a,c,d  

^a OSAKA UNIVERSITY   (Japan)

^b Tokyo Institute of Technology   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; NUCLEOSOME ASSEMBLY PROTEIN 1; TBKBP1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; GENE ORDER; GENE TARGETING; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 84878035924     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203155     Document Type: Article

References (50)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
2. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258. (Pubitemid 32772607)
3. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993. (Pubitemid 37521540)
4. Iwasaki, A., and R. Medzhitov. 2010. Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
5. Yoneyama, M., and T. Fujita. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227: 54-65.
6. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
7. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9: 692-703.
8. Kaisho, T., O. Takeuchi, T. Kawai, K. Hoshino, and S. Akira. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166: 5688-5694. (Pubitemid 32374193)
9. Pulendran, B., and R. Ahmed. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124: 849-863. (Pubitemid 43261457)
10. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
11. Heath, W. R., and F. R. Carbone. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10: 1237-1244.
12. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
13. Hildner, K., B. T. Edelson, W. E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B. U. Schraml, E. R. Unanue, M. S. Diamond, et al. 2008. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322: 1097-1100.
14. Naik, S. H., A. I. Proietto, N. S. Wilson, A. Dakic, P. Schnorrer, M. Fuchsberger, M. H. Lahoud, M. O'Keeffe, Q. X. Shao, W. F. Chen, et al. 2005. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597. (Pubitemid 40705619)
15. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
16. Metcalf, D. 2008. Hematopoietic cytokines. Blood 111: 485-491.
17. Guthridge, M. A., F. C. Stomski, D. Thomas, J. M. Woodcock, C. J. Bagley, M. C. Berndt, and A. F. Lopez. 1998. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells 16: 301-313. (Pubitemid 28455645)
18. Hansen, G., T. R. Hercus, B. J. McClure, F. C. Stomski, M. Dottore, J. Powell, H. Ramshaw, J. M. Woodcock, Y. Xu, M. Guthridge, et al. 2008. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134: 496-507.
19. Sakamaki, K., I. Miyajima, T. Kitamura, and A. Miyajima. 1992. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 11: 3541-3549.
20. Sebastián, C., M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada. 2008. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180: 5898-5906.
21. Tamura, T., P. Tailor, K. Yamaoka, H. J. Kong, H. Tsujimura, J. J. O'Shea, H. Singh, and K. Ozato. 2005. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174: 2573-2581. (Pubitemid 40279670)
22. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360. (Pubitemid 44354220)
23. Ryzhakov, G., and F. Randow. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26: 3180-3190. (Pubitemid 47057483)
24. Guo, B., and G. Cheng. 2007. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282: 11817-11826. (Pubitemid 47100710)
25. Sasai, M., H. Oshiumi, M. Matsumoto, N. Inoue, F. Fujita, M. Nakanishi, and T. Seya. 2005. Cutting edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J. Immunol. 174: 27-30. (Pubitemid 40007387)
26. Kawagoe, T., O. Takeuchi, Y. Takabatake, H. Kato, Y. Isaka, T. Tsujimura, and S. Akira. 2009. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat. Immunol. 10: 965-972.
27. Maruyama, K., T. Kawagoe, T. Kondo, S. Akira, and O. Takeuchi. 2012. TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation. J. Biol. Chem. 287: 29114-29124.
28. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
29. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101- 105.
30. Saitoh, T., T. Satoh, N. Yamamoto, S. Uematsu, O. Takeuchi, T. Kawai, and S. Akira. 2011. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 34: 352-363.
31. Fujimoto, K., T. Karuppuchamy, N. Takemura, M. Shimohigoshi, T. Machida, Y. Haseda, T. Aoshi, K. J. Ishii, S. Akira, and S. Uematsu. 2011. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity. J. Immunol. 186: 6287-6295.
32. Goncalves, A., T. Bürckstümmer, E. Dixit, R. Scheicher, M. W. Górna, E. Karayel, C. Sugar, A. Stukalov, T. Berg, R. Kralovics, et al. 2011. Functional dissection of the TBK1 molecular network. PLoS ONE 6: e23971.
33. Sasai, M., M. Shingai, K. Funami, M. Yoneyama, T. Fujita, M. Matsumoto, and T. Seya. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177: 8676-8683. (Pubitemid 44893832)
34. Chien, Y., S. Kim, R. Bumeister, Y. M. Loo, S. W. Kwon, C. L. Johnson, M. G. Balakireva, Y. Romeo, L. Kopelovich, M. Gale, Jr., et al. 2006. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127: 157-170. (Pubitemid 44472624)
35. Ou, Y. H., M. Torres, R. Ram, E. Formstecher, C. Roland, T. Cheng, R. Brekken, R. Wurz, A. Tasker, T. Polverino, et al. 2011. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol. Cell 41: 458-470.
36. Fujita, F., Y. Taniguchi, T. Kato, Y. Narita, A. Furuya, T. Ogawa, H. Sakurai, T. Joh, M. Itoh, M. Delhase, et al. 2003. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol. Cell. Biol. 23: 7780-7793. (Pubitemid 37271475)
37. Oganesyan, G., S. K. Saha, B. Guo, J. Q. He, A. Shahangian, B. Zarnegar, A. Perry, and G. Cheng. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439: 208-211. (Pubitemid 43083142)
38. Bonnard, M., C. Mirtsos, S. Suzuki, K. Graham, J. Huang, M. Ng, A. Itié, A. Wakeham, A. Shahinian, W. J. Henzel, et al. 2000. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19: 4976-4985.
39. Matsui, K., Y. Kumagai, H. Kato, S. Sato, T. Kawagoe, S. Uematsu, O. Takeuchi, and S. Akira. 2006. Cutting edge: Role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177: 5785-5789. (Pubitemid 44628791)
40. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
41. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
42. Boehm, J. S., J. J. Zhao, J. Yao, S. Y. Kim, R. Firestein, I. F. Dunn, S. K. Sjostrom, L. A. Garraway, S. Weremowicz, A. L. Richardson, et al. 2007. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129: 1065-1079. (Pubitemid 46891036)
43. Joung, S. M., Z. Y. Park, S. Rani, O. Takeuchi, S. Akira, and J. Y. Lee. 2011. Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1. J. Immunol. 186: 499-507.
44. Xie, X., D. Zhang, B. Zhao, M. K. Lu, M. You, G. Condorelli, C. Y. Wang, and K. L. Guan. 2011. IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. USA 108: 6474-6479.
45. Vremec, D., G. J. Lieschke, A. R. Dunn, L. Robb, D. Metcalf, and K. Shortman. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27: 40-44. (Pubitemid 27046056)
46. Palucka, K., and J. Banchereau. 2012. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12: 265-277.
47. Turnis, M. E., and C. M. Rooney. 2010. Enhancement of dendritic cells as vaccines for cancer. Immunotherapy 2: 847-862.
48. Palucka, K., H. Ueno, and J. Banchereau. 2011. Recent developments in cancer vaccines. J. Immunol. 186: 1325-1331.
49. Cho, N. H., T. C. Cheong, J. H. Min, J. H. Wu, S. J. Lee, D. Kim, J. S. Yang, S. Kim, Y. K. Kim, and S. Y. Seong. 2011. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6: 675-682.
50. Yi, H., C. Guo, X. Yu, P. Gao, J. Qian, D. Zuo, M. H. Manjili, P. B. Fisher, J. R. Subjeck, and X. Y. Wang. 2011. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer Res. 71: 6611-6620.